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Introduction 
 
DNA mismatch repair is a highly conserved system for correcting mispaired or 
extra helical nucleotide lesions in DNA.  Lesions may result from misincorporation errors 
during DNA replication, from chemical and physical damage, or from genetic 
recombination between parental DNA strands lacking perfect homology.  In particular, 
this pathway helps to maintain genomic integrity via the repair of polymerase 
misincorporation errors by increasing the fidelity of DNA synthesis 1,000 fold1.  The 
importance of the mismatch repair pathway is underscored by the fact that mutations in 
key mismatch repair genes are the cause of certain types of cancers as well as 
neurodegenerative diseases8,9.   
Examination of the mismatch repair system in Escherichia coli provides an 
important model for elucidating similar pathways in eukaryotes.  The proteins responsible 
for initiating mismatch repair in E. coli are MutS, MutL, and MutH.  Single base 
mismatches and insertion-deletion loops up to four nucleotides are recognized by the 
MutS homodimer2,3.  The mechanism of mismatch repair is controversial53.  However, 
the majority of data are consistent with the conclusion that ADP-bound MutS specifically 
recognizes these lesions which provoke ADP?ATP exchange and loading of multiple 
MutS sliding clamps on the DNA4.  ATP-dependent recruitment of MutL by lesion-
bound MutS is thought to transmit a signal downstream to MutH, an endonuclease that 
recognizes and nicks unmethylated GATC sequences in the daughter strand following 
DNA replication.  The nick directs unwinding of the DNA to the site of the mismatch by 
UvrD helicase, while exonucleolytic cleavage of the newly synthesized strand is 
accomplished by one of four single-strand specific proteins (RecJ, ExoVII, ExoX, and 
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ExoI)5-7.  The resulting gap is resynthesized and sealed by polymerase III and DNA 
ligase (Fig. 1).   
The mismatch repair reaction in eukaryotes is significantly more complex.  Many 
homologs of the MutS and MutL proteins have been discovered and partially 
characterized (Table 1).  No MutH homologs have been identified in higher organisms, 
which strongly suggests that strand discrimination in the eukayotic mismatch repair 
pathway occurs via an alternate route, possibly from single-stranded nicks or gaps in 
newly replicated DNA that have not been formed by DNA ligase.  The major MutS 
homologs (MSH) responsible for the recognition and initiation of mismatch repair in 
humans are MSH2, MSH3, and MSH6.  MSH2 forms heterodimers with both MSH3 and 
MSH6.  MSH2-MSH6 and MSH2-MSH3 have different but overlapping lesion 
specificities10.  MSH2-MSH6 functions primarily in the repair of base-base mismatches, 
and to a lesser extent small insertion-deletion loops (IDL)11.  MSH2-MSH3 also can 
recognize and bind single base mismatches, but has a preference for larger IDLs 
generally less than 16 nucleotides12,13.  While the eukaryotic mismatch repair system has 
been extensively studied, many questions remain regarding its fundamental mechanism 
including the role of activated nucleotides, downstream signaling, strand discrimination, 
and many others.  Answers to these questions will provide a more detailed understanding 
of how the mismatch repair system works, and how defects can have debilitating 
pathological consequences such as cancer and neurodegenerative disease.   
This research project has focused primarily on human MSH2-MSH3, and to a 
lesser extent MSH2-MSH6.  In the forthcoming chapters, I explain my work on 
constructing useful mutations that will be used to characterize the ATP and DNA-binding 
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mechanics of MSH2-MSH3.  I will discuss a detailed purification scheme that results in 
active wild-type MSH2-MSH3.  I will detail the development of mutations made in the 
ATP-binding domain of both MSH2 and MSH3 and explain their significance.  I will 
discuss the development of a fluorescently-tagged CFP-MSH3 hybrid which allows 
understanding of the conformational changes upon IDL binding using fluorescence 
resonance energy transfer, and discuss the substrates created and used in all the 
experiments with MSH2-MSH3.  
 
 
Figure 1.  The Prokaryotic Mismatch Repair Model.  MutS binds to mismatch DNA which recruits 
MutL and signals downstream to MutH in an ATP dependent process.  Excision of the DNA tract between 
the nick and the mismatch occur by identical mechanisms, but require different nucleases depending on the 
location of the nick. 
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      Table 1. Currently identified MutS and MutL homologs  (Table reproduced from Fishel et al.   
       2000.) 
 
 
Mismatch Repair and Disease 
Hereditary non-polyposis colorectal cancer (HNPCC) is the most common form 
of colorectal cancer and is intimately associated with mismatch repair14.  Germline 
mutations in any one of five mismatch repair genes, MSH2, MSH3, MSH6, PMS2 and 
PMS1 increases susceptibility to HNPCC15-19.  The majority (80%) of HNPCC-associated 
mismatch repair mutations occur in MSH2 and MLH1, with other mismatch repair genes 
being responsible for only a fraction of cases14, 20.  HNPCC carriers have a 90% chance of 
developing cancer by the time they reach seventy years of age21.   
One of the clues that helped link colorectal cancer and mismatch repair was the 
observation that a fraction of colorectal tumors display microsatellite instability (MSI)22.  
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Microsatellites are short repetitive sequences in DNA usually 1-6 base pairs occurring 
throughout the genome, the most common repeat being (CA)n.  The reason these tracts of 
DNA become unstable is thought to occur from polymerase slippage during replication, 
resulting in either an extension or shortening of these sequences if left unrepaired by the 
mismatch repair pathway23( Fig. 2).  In a mismatch repair-deficient environment, 
microsatellites become unstable and display changes in the length of the respective repeat 
sequences.  Genes containing microsatellites in their coding regions are susceptible to 
inactivation through frameshift mutations.  Inactivation of such genes may ultimately 
lead to cancer. 
Interestingly, while mutations in mismatch repair genes are an underlying cause 
of HNPCC and other cancers, other fully functional mismatch repair genes appear to be 
implicated in the pathogenesis of trinucleotide expansion of CAG and CTG sequences 
found in at least eight hereditary and progressive neurodegenerative and muscular 
disorders24-26.  One of these disorders, Huntington’s disease (HD) contains repeats of 
CAG bases found within the coding sequence of the Huntingtin gene.  Normal unaffected 
individuals have 6-29 CAG repeats, carriers of the disease have 29-35, while affected 
individuals have 36-120 repeats27.  The expansion of these repeats in the coding region of 
the gene produces long polyglutamine tracts (CAG codes for glutamine) in the protein, 
disrupting normal protein function and destroying brain cells. 
The underlying cause for CAG expansion has been linked to MSH2-MSH3 
mismatch repair proteins.  Experiments in mouse models have suggested that functional 
MSH2 and MSH3 are necessary for the expansion of CAG repeats in HD29.  It seems 
discrepant that MSH2-MSH3, which is responsible for repairing DNA, is facilitating 
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mutation and causing disease.  The nature of this relationship is still under investigation, 
and a possible mechanism is thought to reside in the CAG repeat secondary structure and 
its interactions with MSH2-MSH327.   Long stretches of CAG repeats form hairpin loops 
with a mismatched base every third nucleotide.  These loops form stable hairpin 
structures that fail to be repaired in vivo, while loops comprised of triplets not capable of 
forming secondary structure were effectively removed30.  Incorporation of these 
stabilized-loop intermediates into DNA leads to trinucleotide repeat expansion in a 
mechanism similar to that of microsatellite instability.  MSH2-MSH3 is thought to assist 
in this process by either failing to correct post-replicative slippage errors or by further 
stabilizing CAG loop intermediates27.  It is interesting to note that binding of MSH2-
MSH3 to CAG hairpin complexes has been suggested to alter many of its biochemical 
properties, including its affinity for nucleotides and its tertiary structure29.  More 
specifically, binding of MSH2-MSH3 to trinucleotide hairpins causes a conformational 
transition that inhibits its ATPase activity and likely inhibits its ability to signal the 
mismatch repair complex downstream29.  A detailed study of the conformation of MSH2-
MSH3 binding to CAG hairpin structures compared to normal IDLs, as well as controlled 
studies on the effect of such binding on adenosine nucleotide processing would be crucial 
to elucidate the exact role of MSH2-MSH3 in trinucleotide repeat expansion.         
  
8 
 
 
 Figure 2.  Polymerase Slippage on Microsatellite Tracts During Replication.  During  
replication, strand slippage can form intermediates stabilized by downstream base pairs.  If left  
uncorrected by mismatch repair, the following generation contains either an extension or reversal  
of the repeat tract, causing frameshift mutations in certain genes (Figure reproduced from T.  
Kunkel, 1993.  Nature 365: 207-208)  
 
 
 
 
Results 
Mutation of the ATP binding domain of MSH2 and MSH3 
 Many of the processes of mismatch repair are not well understood, but crystal 
structures of both MutS and MSH2-MSH6 binding to mismatch DNA have provided 
clues to the structural and functional basis for mismatch recognition33,34.  All of the MSH 
proteins have a conserved Walker A motif near the C terminus which binds adenine 
nucleotides ATP and ADP32.  While MSH2-MSH6 and MSH2-MSH3 are structurally 
very similar (both contain conserved DNA-binding domains, ATP domains, and share a 
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common MSH2 subunit), the mechanism by which these proteins recognize DNA lesions 
and bind ATP have been suggested to be different35.  The MSH2 and MSH3 subunits 
appear to bind ATP or ADP with similar affinity in the absence of DNA.  Upon loop 
recognition, MSH2 hydrolyzes ATP and binds ADP while the ATP-binding domain of 
MSH3 remains empty35.  The lesion-bound MSH3 subunit then binds and hydrolyzes 
ATP, which promotes ADP? ATP exchange in MSH235.  Similar to MSH2-MSH6, it is 
reasonable to assume that the ATP-MSH2-MSH3-ADP intermediate would undergo 
hydrolysis-independent diffusion along the DNA, possibly to signal other components of 
mismatch repair13,36.  Because no ADP/ATP-binding-defective mutations were examined, 
this hypothesis awaits experimental verification. 
 To provide a more detailed study regarding the role of adenine nucleotide in 
lesion recognition and repair by MSH2-MSH3, two mutations were made in the ATP-
binding domain of MSH3, and co-purified with a homologous mutant of MSH2.  The 
mutants constructed in MSH3 were lysine to arginine and lysine to alanine mutations at 
amino acid 893 (K893R and K893A, respectively).  Similarly, the mutations used in 
MSH2 were K675R and K675A. 
Mutations were introduced using an overlapping PCR method, the general 
schematic of which appears in Figure 3.  The human MSH3 gene was provided cloned 
into the pFastBac1 plasmid between the Nde I and HindIII restriction sites (a gift from 
Nidhi Punja).  Two unique restriction sites were identified flanking the region of the 
mutation: a BstEII site 5’ and an NcoI site 3’ of the desired mutation target sequence.  Six 
primers were synthesized, one contained the BstEII restriction sequence designed to 
anneal to the non-coding strand (BstEII-f; 5’-AAA-GAA-GTG-GGT-GAC-CCA-3’, 
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where f and r denote forward and reverse primers); a mutation primer containing the 
desired mutation base sequence to anneal to the coding strand (K893R-r; 5’-GTA-GGA-
GCT-TCT-TCC-ACC-CAT-3’); a primer complementary to K893R-r (K893R-f; 5’-
ATG-GGT-GGA-AGA-AGC-TCC-TAC-3’) and a primer containing the Nco I 
restriction sequence designed to anneal to the non-coding strand (NcoI-r; 5’-CGA-GCT-
CCC-ATG-GTC-ATA-AT-3’).  Two primers containing the K893A mutation were 
designed similar to the K893R mutation primers, K893A-f (5’-ATG-GGT-GGA-GCG-
AGC-TCC-TAC-3’) and K893A-r (5’-GTA-GGA-GCT-CGC-TCC-ACC-CAT-3’).  Four 
separate PCR reactions were set up utilizing the following primer combinations; BstEII-f 
& K893R-r, NcoI-r & K893R-f; BstEII-f & K893A-r, NcoI-r & K893A-f.  The separate 
PCR mutation products were gel purified, combined, and used as templates for another 
set of PCR reactions utilizing the outside restriction sequence primers (BstEII-f & NcoI-
r).  The resulting 1.8 kb band was digested with BstEII and NcoI (New England Biolabs) 
and gel purified.  pFastBac1 with MSH3 was also digested with the same enzymes, and 
the resulting fragment was ligated to the PCR product overnight at 16 ºC.  The mixture 
was then transformed into XL-10 Gold (Stratagene) competent cells and plated on LB 
plates containing ampicillin.  Colonies were screened for the desired insert by 
linearization with NcoI and analyzed by gel electrophoresis.  Integrity of the final 
mutation product was confirmed by sequencing.   
 
Expression of Mutant Protein via Recombinant Bacmid 
 Following confirmation of the mutant gene product, 5 ng of mutant (MSH3 
(K893R) and MSH3(K893A)) plasmid were transformed into DH10Bac E. coli cells and 
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plated on LB agar plates containing 50 μg/mL kanamycin, 7 μg, mL gentamicin, 10 
μg/mL tetracycline, 100 μg/mL Bluo-gal, and 40 μg/mL isopropyl β-D-1-
thiogalactopyranoside.  Colonies containing recombinant bacmid appeared white while 
those without recombination appeared blue.  The plates were incubated for 48 hours at  
37 ºC.  Five white colonies were re-streaked on fresh plates and allowed to grow 
overnight.  Single colonies were inoculated in 5 mL of LB media containing 50 μg/mL 
kanamycin, 7 μg, mL gentamicin, and 10 μg/mL tetracycline and grown for 16 hours at 
37 ºC.  Recombinant bacmid DNA was isolated from the overnight culture by miniprep 
and resuspended in buffer TE to a final concentration of 4 mg/mL. 
 For bacmid transfections, 9 x 105 Sf9 insect cells were seeded in a 6-well tissue 
culture plate containing 2 mL of Sf-900 II SFM media with 2 μg/mL gentamicin.  Cells 
were allowed to attach to the plate for 1 hour at 27 ºC.  During this period, 6 μg bacmid 
DNA was diluted in 600 μL of Sf-900 II media and combined with 600 μL of media 
containing 36 μL Cellfectin Reagent (Invitrogen) and incubated for 45 minutes at room 
temperature.  5.4 mL unsupplemented media was added to the Cellfectin/Bacmid mixture 
and mixed well.  Media was then removed from the 6-well plate containing cells and 1 
mL of the Cellfectin/Bacmid mixture was placed in each well and allowed to incubate for 
5 hours at 27 ºC.  The media was removed from the wells and 2 mL of Sf-900 II media 
supplemented with 2 μg/mL gentamicin and GlutaMAX (20 mM L-alanyl-L-glutamine; 
Invitrogen) was added and incubated for 72 hours at 27 ºC. 
 Cells were visually inspected after 72 hours for signs of viral infection which 
include cessation of cell growth, detachment from the plate, and a granular appearance 
when compared to a cell-only control.  After verification of successful infection, the 
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media from each well was collected and placed in a 15 mL conical vial and subjected to 
centrifugation at 500 x g for 5 minutes to pellet cells and debris.  The supernatant was 
collected, stored at 4 ºC, and labled P1 (Phase-1) viral stock.  The P1 stock was used to 
generate high-titer P2 and P3 viral stocks.  0.5 mL of P1 viral stock was used to inoculate 
a 10 mL Sf-9 cell culture suspension at 2 x 106 cells/mL.  The cells were incubated at  
27 ºC for 72 hours then centrifuged at 500 x g for 5 minutes.  The supernatant was 
collected and stored as P2 viral stock.  0.5 mL of P2 was used to infect 15 mL of cells at 
2 x 106 cells/mL.  The resulting culture was incubated for 72 hours at 27 ºC, centrifuged, 
and the supernatant stored as P3 viral stock.      
P3 viral stocks of all MSH2 and MSH3 mutants (lysine-to-arginine and lysine-to-
alanine) were created.  P3 viral stock for MSH2 (K675A), MSH3 (K893A) and wild-type 
MSH2 and MSH3 were used to infect 200 mL of Sf-9 cells yielding the following 
permutations of expressed protein; MSH2(wt)-MSH3(wt), MSH2(wt)-MSH3(K893A), 
MSH2(K675A)-MSH3(wt),  and MSH2(K675A)-MSH3(K893A) where ‘wt’ denotes 
wild-type.  To check for expression, 1 mL of cells was collected in a microcentrifuge 
tube following 48 hours of infection and centrifuged for 5 minutes at 1000 x g.  The 
pellet was resuspended in 150 μL H20, 100 uL PBS, and 50 μL SDS dye ( 350 mM Tris-
HCl (pH 6.8), 30% glycerol, 10% SDS (w/v), 600 mM DTT and a tinch of bromophenol 
blue), boiled for 10 minutes and centrifuged for 10 minutes at 12,000 x g.  10 μL of the 
solution was loaded on an 8% polyacrylamide gel to verify expression of the protein (Fig. 
10).  Following verification, infected Sf9 cells were harvested and suspended in wash 
buffer A (150 mM NaCl, 25 mM HEPES-NaOH (pH 8.1), 10% glycerol, 0.5 mM EDTA 
and a protease inhibitor cocktail (0.5 mM phenylmethyl sulfonyl fluoride (PMSF), 0.8 
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ug/mL pepstatin and 0.8 ug/mL leupeptin), pelleted and resuspended in freeze buffer B 
(300 mM NaCl, 20 mM imidazole, 25 mM HEPES-NaOH (pH 8.1), 10% glycerol, and 
the protease inhibitor cocktail followed by flash freezing in liquid nitrogen and storage at 
-80 ºC .   
     
   
                 Figure 3. Schematic of Site Directed Mutagenesis by Overlapping PCR.  Outside primers     
                    carrying unique restriction sequences are combined with internal primers flanking the mutation   
                    site with the desired codon change in a PCR reaction.  The products of which are used in equal  
                    proportion as template for a PCR reaction utilizing the outside primers.  The result is a section                 
                    of  the gene carrying the desired mutation which is then ligated to the original gene. (Figure   
                    reproduced from M. Blaber, Florida State University  
 
 The mutations created in MSH2 and MSH3 were done specifically with the 
intention of studying how each subunit of the dimer binds and hydrolyzes ATP upon IDL 
recognition in protein-crosslinking experiments.  Each mutation was made in the Walker 
A nucleotide-binding motif previously described.  These mutations will provide 
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information regarding which subunit binds which nucleotide (ATP or ADP) and how 
these change before and after lesion binding.  The lysine-to-arginine mutations in the 
Walker A region allow for nucleotide binding but prevent ATP hydrolysis, while the 
lysine-to-alanine mutations are deficient in nucleotide binding altogether. 
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                          Figure 10. Expression of Mutant MSH2-MSH3.  8% Polyacrylamide  
                               gels showing protein expression in Sf9 cells 48 hours after infection with  
                               P3 viral stock.  (A) MSH2-MSH3 wild type; (B) MSH2(K675A)-MSH3 
                               (K893A); (C) MSH2(K675A)-MSH3(WT); (D) MSH2(WT)-MSH3(K893A)     
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   Figure 9.  Sequences of mutant MSH3 (K893R) and MSH3 (K893A) showing codon mutations.  The    
   codon for lysine 893 in MSH3 is AAG; it was mutated to AGA in MSH3(K893R) and to   
   GCG in MSH (K893A).  Sequences were aligned against wild-type MSH3 to scan for random  
 
   mutations using ClustalW2 software. 
 
 CFP-MSH3 hybrid and Conformational Transitions   
 The discovery and purification of the fluorescent jellyfish proteins has allowed 
biochemists to look into nanometer-scale conformational transitions associated with 
protein-DNA interaction, along with a host of other applications.  Mutations in the 
original GFP (green fluorescent protein) have provided a variation of fluorescent proteins 
with variable excitation and emission spectra37,38.  These physical characteristics of the 
fluorescent proteins have been utilized using fluorescence resonance energy transfer 
(FRET).  Resonance energy transfer occurs whenever the emission spectrum of a 
fluorophore, called the donor, overlaps with the absorption spectrum of another molecule, 
called the acceptor39.  The extent of the spectral overlap between the donor and acceptor, 
as well as the distance between them determines the extent of energy transfer.  The 
distance between the donor and acceptor pair can be calculated directly from the 
measured transfer efficiency of the pair, providing an in vitro “spectroscopic ruler” with 
which to measure distances between sites on proteins tagged with fluorophores40.   
CFP (cyan fluorescent proteins) and YFP (yellow fluorescent protein) are ideal 
candidates to study molecular interactions due to their high photostability, and the fact 
that their adsorption and emission spectra are at favorably long wavelengths41.  The donor 
and acceptor need to be within 15-60 Å for FRET to occur, which is comparable to the 
size of biological macromolecules.  MSH2-MSH3 is an ideal candidate to study to how 
the protein changes conformations upon binding to IDLs as well as the trinucleotide 
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repeats found in HD.  The sensitivity of FRET is such that we will be able to determine 
how these conformational changes may influence other biochemical characteristics of the 
protein such as that seen when MSH2-MSH3 binds to CAG hairpin loops29.  To 
characterize and understand physical changes that occur upon lesion recognition, a CFP-
MSH3 hybrid was constructed, and will be coexpressed and purified with a YFP-MSH2 
hybrid constructed previously by Sarah Javaid.   
To construct this hybrid, a pECFP-C1 vector containing the CFP gene was 
purchased from Clontech.  PCR primers were designed and purchased from IDT.  The 
forward primer (5’-CCC GCA TGC CGC CACC ATG CAC CAC CAC CAC CAC CAC 
ATG GTG AGC AAG GGC-3’) introduces an SphI restriction site, as well as a Kozak 
consensus translation initiation site for increased translational efficiency42.  Also 
incorporated is a His6 tag for purification on a nickel column, all on the N-terminus of the 
CFP gene.  The reverse primer (5’-CCC CAT ATG ACC ACC CTT GTA CAG CTC 
GTC CAT GCC) will bind to the last 18 base pairs of the CFP gene, remove the stop 
codon, and place two glycine residues to increase protein mobility and degrees of 
freedom.   
A PCR reaction was set up utilizing these primers and the pECFP-C1 vector as 
template.  The resulting 759 bp band was gel extracted and purified, digested with both 
SphI and NdeI (New England Biolabs) and gel purified again.  Simultaneously, a pET29a 
vector harboring the MSH3 gene cloned between SphI and NdeI was digested with the 
same enzymes, and gel purified.  The resulting insert and vector were ligated overnight at 
16 ºC and transformed into XL-1 blue competent E. coli cells (Stratagene) and plated on 
agar plates containing kanamycin (60 μg/mL).  Plasmid DNA was isolated from selected 
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colonies and analyzed for the CFP insert by linearization with SphI and observing a 10 kb 
band when subjected to gel electrophoresis.  A pFastBac1 vector and the Pet29a-CFP-
MSH3 vector were both digested with SphI and HindIII.  The appropriate bands were gel 
purified and ligated to create the CFP-MSH3 hybrid in pFastBac1.  DNA sequencing of 
the subsequent plasmid was done to verify the integrity of the construct (Fig. 9).   
 
 
 
 
Figure 9. Sequence of the CFP-MSH3 Hybrid.  The top chromatogram shows the N-terminus of CFP 
including the Sph I restriction site used for cloning (orange box), the Kozak translation initiation sequence 
(blue box), and the 6 x Histidine tag (red box).  The bottom chromatogram shows the C-terminus of CFP 
connected to the N-terminus of MSH3 which includes a two residue glycine linker and the Nde I site used 
in cloning (orange box). 
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Overexpression and Purification of MSH2-MSH3 
 The original MSH2 and MSH3 clones in pFastBac1 were a gift from Nidhi Punja.  
MSH2 and MSH3 were co-overexpressed in Sf9 insect cells from recombinant bacmid 
and frozen at -80 ºC as previously described (chapter 3).  All purification steps were 
carried out at 4 ºC.  Cells in freeze buffer (300 mM NaCl, 25 mM HEPES-NaOH (pH 
8.1), 20 mM imidazole, 10% glycerol, and protease cocktail) were thawed on ice and 
lysed by repeated passage through a 25 gauge needle.  After centrifugation at 40,000 x g 
for 1 hr, the supernatant was loaded on to a nickel nitrilotriacetic acid Superflow column 
(Qiagen) and equilibrated with 10 % buffer B-1 (25 mM HEPES-NaOH (pH8.1), 300 
mM NaCl, 10% glycerol, 0.24 mM PMSF, 0.384 μg /mL pepstatin, 0.384 μg /mL 
leupeptin, 200 mM imidazole).  The protein was eluted with a linear gradient of 
imidazole from 20 mM to 200 mM.  The peak fractions containing MSH2 and MSH3 
were eluted at approximately 75 mM imidazole and were then loaded onto a PBE 94 
(Sigma) column in tandem with a heparin-Sepharose column (GE Healthcare).  The 
column was equilibrated with 30% buffer B-2 (25 mM HEPES-NaOH (pH8.1), 1 mM 
DTT, 0.1 mM EDTA, 10% glycerol, 0.24 mM PMSF, 0.384 μg /mL pepstatin, 0.384 μg 
/mL leupeptin, 1 M NaCl) and the protein was eluted with a linear gradient of salt from 
300 mM to 1 M.  MSH2-MSH3 eluted at approximately 450 mM NaCl.  Peak fractions 
were diluted to 100 mM NaCl with buffer A (25 mM HEPES-NaOH (pH8.1), 1 mM 
DTT, 0.1 mM EDTA, 10% glycerol, 0.24 mM PMSF, 0.384 μg /mL pepstatin, 0.384 μg 
/mL leupeptin) and loaded onto an S-Sepharose Fastflow column (GE Healthcare) 
equilibrated with 10% buffer B-2.  MSH2-MSH3 was eluted with a linear gradient of salt 
from 100 mM to 1 M, with peak fractions eluting at approximately 300 mM.  Peak 
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fractions were then diluted to 100 mM NaCl with buffer A and loaded onto a Mono-S 
column (Pharmacia Biotech) equilibrated with 10% buffer B-2 and eluted with a linear 
gradient of salt from 100 mM to 1 M NaCl.  The protein complex eluted at approximately 
425 mM NaCl.  Peak fractions were collected and diluted to 100 mM NaCl in buffer A 
and directly loaded onto a Mono-Q column (Pharmacia Biotech).  The column was 
equilibrated with 10% buffer B-2 and eluted with a linear gradient of salt from 100 mM 
to 500 mM.  Peak fractions eluted at approximately 200 mM NaCl and were dialyzed 
against 25 mM HEPES-NaOH (pH 8.1), 150 mM NaCl, 1 mM DTT, 0.1 mM EDTA and 
20% glycerol (v/v).  Aliquots were frozen in liquid nitrogen and stored at -80 ºC.  The 
purity of MSH2-MSH3 was analyzed on an 8% SDS-PAGE gel and was found to be 
more than 95% pure by Coomassie staining (Fig.4).  Protein concentration was 
determined by Bradford assay. 
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            Figure 4. Purification of wild-type hMSH2-hMSH3.  An 8% Coomassie stained gel    
              following a five step purification procedure.  Molecular weight markers (Biorad) are shown.   
              (Lane 1) Crude extract from insect cells infected with expression virus containing MSH2 and  
              MSH3; (lane 2) peak fractions from a nickel affinity column eluted with imidazole; (lane 3) peak  
              fractions from a PBE 94 column in tandem with a heparin-Sepharose column and eluted with a  
              NaCl gradient; (lane 4) peak fractions from an S-sepharose column; (lane 5) peak fractions from a  
              mono-S column; (lane 6) pure MSH2-MSH3 after elution with NaCl from a mono-Q column.   
              Arrows indicate hMSH2 (104.7 kD) and hMSH3 (126.75 kDa).    
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Steady-State ATPase activity of MSH2-MSH3 
 ATP binding and hydrolysis and mismatch recognition are the key conserved 
functions carried out by all MutS homologs.  Upon lesion recognition, MSH2-MSH3 
with ADP bound in the MSH2 subunit binds IDL DNA and undergoes ADP?ATP 
exchange13,35.  In this experiment with a 41 bp IDL oligomer, the protein slides off the 
DNA, hydrolyzes ATP and repeats another round of DNA binding forming a cycle 
(fig.5).   
 
 
  Figure 5.  MSH2-MSH3 ATP hydrolysis cycle, based on MSH2-MSH6.   ADP bound   
                             MSH2-MSH3 binds IDL DNA which stimulates ADP? ATP exchange and translocation   
                             along the DNA backbone.  ATP hydrolysis revives the competent lesion recognition   
                             complex (figure reproduced from R. Fishel, 1998.  Mismatch repair, molecular switches,  
                             and signal transduction.  Genes Dev.  12: 2096-2101) 
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Figure 6 demonstrates how the inherent ATP hydrolysis (ATPase) activity of MSH2-
MSH3 is stimulated by DNA containing an eight base pair IDL, and that homoduplex 
DNA fails to effectively trigger ATPase activity. 
 
 
Figure 6. ATPase activity of hMSH2-hMSH3.  IDL stimulates the inherent ATPase activity of the MSH2-
MSH3 heterodimer.  ATPase activity in the prescence of homoduplex DNA is attenuated. 
 
DNA Substrates 
The sequences of the DNA substrates are as follows: G/C DNA, 5’-CCG CTG AAT TGC 
ACC GAG CTC GAT CCT CGA TGA TCC TAA GC-3’; IDL DNA, 5’-CCG CTG 
AAT TGC ACC GAG CTC CA CA CA CA GAT CCT CGA TGA TCC TAA GC-3’.  
Complimentary strand for the G/C and IDL oligomer, 5’ GCT TAG GAT CAT CGA 
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GGA TCG AGC TCG GTG CAA TTC AGC GG-3’.  Oligomers were ordered from 
Integrated DNA Technologies and annealed over night at 55 ºC in annealing buffer ( 100 
mM NaCl, 10 mM Tris (pH 8.0), and 2 mM EDTA), and purified by HPLC (by Thomas 
Haver).  Steady-state ATPase assays were performed in reaction buffer ( 130 mM NaCl, 
25 mM HEPES-NaOH (pH 7.8), 1 mM DTT, 200 ug/mL acetlylated BSA (Promega), 10 
mM MgCl2,  15 nM [g-32P]-ATP) and varying amounts of unlabelled ATP as described.  
Reactions were performed in the presence of either IDL DNA or G/C DNA at 200 nM.  
Reactions were initiated by addition of 10, 30, and 50 nM MSH2-MSH3 depending on 
ATP concentration.  Reactions were incubated for 30 min at 37 ºC and stopped by the 
addition of 400 uL of charcoal solution (10% activated charcoal (Sigma), 10 mM EDTA).  
Samples were centrifuged at 14,000 RPM for 15 minutes to pellet the charcoal and 100 
uL supernatant was removed and counted by liquid scintillation to measure the released 
phosphate.  At different ATP concentrations, the velocity of the reaction was measured as 
pmol ATP/min by normalizing for the amount of protein in the sample and plotted vs. 
ATP concentration.    
 
Real time binding-dissociation of hMSH2-hMSH3 using surface plasmon resonance 
Surface plasmon resonance (SPR) is a phenomenon used to study biomolecular 
interactions that occurs at an interface between media with different refractive indices.  
This technology was exploited using a Biacore 3000 to follow binding interactions of the 
hMSH2-hMSH3 heterodimer in real time.  In these experiments, the sensor chip utilized 
consists of a carboxymethylated dextran matrix immobilized with streptavidin.  The 
streptavidin is used specifically to bind to molecules that are tagged with biotin, due to 
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the extremely high affinity these two molecules have for each other (Kd ≈ 10-15 M)43.  The 
DNA oligomers used in this study were identical to those used in the ATPase experiment 
with the exception that they were biotinylated at the 3’ end for binding to the sensor chip.   
The integral component essential for an SPR experiment is the optical system 
which is focused on the sensor chip containing a layer of gold on glass, which provides 
the necessary components for detection44.  The other side of the gold contains 
streptavidin covalently linked to the sensor chips which permits binding of the 
biotinylated DNA and houses the flow channel through which protein and buffer flow 
(fig. 7).  Binding of protein to the immobilized DNA causes a change in the refractive 
index, and thus a change in the SPR angle.  The SPR angle change is reported as 
resonance units (RU), and a 1000 RU response equals a surface concentration change of 
approximately 1 ng/mm2 (45, 46) .   
The basic experimental reaction is visualized in Figure 7.  A baseline is first 
established with buffer only as a reference.  With the DNA immobilized on the sensor 
chip, the protein solution is injected and binding is monitored in real time by a change in 
SPR angle as the solution flows over the surface.  Buffer can then be passed through the 
system and dissociation of the protein from the DNA can be measured.  The flow cell is 
regenerated by passing through a solution of 1 M NaCl which removes any remaining 
bound protein from the DNA.  A baseline is then reestablished and the experiment can be 
repeated with alteration of experimental variables (protein concentration as an example). 
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Figure 7. Schematic and Experimental  Outline of SPR.  The top panel illustrates the components of the 
SPR experiment including the sensor chip containing a dextran matrix of streptavidin molecules bound by 
biotinylated DNA (blue ovals) and the compound, in this case MSH2-MSH3.  The bottom panel shows the 
steps in a standard SPR experiment; the change in SPR angle is converted to an RU versus time response 
(figure reproduced from Nguyen, B.,  Tanious, F. A.,  Wilson, W. D.  2006.)  
 
 In this experiment, a sensor chip SA (Biacore) was used to immobilize both IDL 
DNA and homo duplex DNA at a concentration of 1 ng/uL.  After attaching DNA to the 
chip, binding buffer (0.005% Surfactant, 25 mM HEPES (pH 7.8), 130 mM NaCl, 10% 
glycerol, 1 mM DTT, 10 mM MgCl2, 150 ug/mL BSA) was passed through to establish a 
baseline concentration with no protein.  After stabilization of the baseline, protein was 
passed through the system and binding was observed until saturation was reached at 
which point binding buffer was again added to remove any unbound protein.  Next an 
ATP buffer (0.005% Surfactant, 25 mM HEPES (pH 7.8), 130 mM NaCl, 10% glycerol, 
1 mM DTT, 10 mM MgCl2, 150 ug/mL BSA, 1 mM ATP) was passed through the 
system, followed by a 1 M salt buffer (0.005% Surfactant, 25 mM HEPES (pH 7.8), 130 
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mM NaCl, 10% glycerol, 1 mM DTT, 10 mM MgCl2, 150 ug/mL BSA, 1 M NaCl) to 
remove any bound protein from the DNA and regenerate the chip.  Binding buffer was 
again passed through to reestablish the base line and repeat the experiment at higher 
concentrations of protein. 
 
ATP induces rapid dissociation of MSH2-MSH3 
 Previous studies have shown that the addition of ATP to IDL-bound MSH2-
MSH3 results is dissociation13.  This is in contrast to studies with MSH2-MSH3 in yeast 
which show that the heterodimer remains stably bound to small IDL DNA in the presence 
of ATP47.  In the experiment illustrated in Figure 8, increasing titrations of MSH2-MSH3 
through the system show increased binding to IDL DNA to the point of saturation, at 
which point buffer is passed through to remove unbound protein.  After stabilization, an 
injection of a 1mM ATP buffer resulted in immediate dissociation of almost all protein 
from the DNA.  Identical experiments were done simultaneously with homoduplex DNA.  
MSH2-MSH3 did not readily bind non-mismatch DNA at low concentrations.  Increasing 
the concentration of protein in the solution forced binding that was either non-specific or 
was induced by the free 5’ end of the DNA which has been shown to induce binding by 
MSH2-MSH636.    
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    Figure 8. A representative sensogram revealing real-time binding of MSH2-MSH3    
     to IDL and homoduplex DNA, and rapid dissociation by the addition of ATP. Buffer is    
     injected  into the system to establish a baseline response after which varying concentrations of protein  
     are added (first injection peak).  After binding is complete more buffer is passed through the system to  
     clear any unbound protein after which a buffer containing 1 mM ATP is added which induces immediate  
     dissociation (Top section: IDL DNA   Bottom section: homoduplex DNA) 
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 Discussion 
 There are currently two representative models for mismatch repair.  One model 
suggests that MutS and its homologs bind mismatch DNA followed by association with 
MutL or its homologs1.  This protein DNA complex is then hypothesized to translocate 
on the DNA bi-directionally in an ATP-dependent manner to the site of the incision prior 
to the excision/repair reaction48.  The results presented in part here and in previous 
publications for the MutS homologs MSH2-MSH3 and MSH2-MSH6 provide an 
alternative model, mainly that the MSH proteins operate as an adenosine nucleotide-
regulated molecular switch13,31,36.  The molecular switch model suggests that ADP ? 
ATP exchange provoked by mismatch DNA results in an ATP-bound sliding clamp that 
diffuses along DNA to signal downstream mismatch repair factors, as opposed to relying 
on ATP hydrolysis to drive motion of the protein along the DNA.  ATP then induces 
release of the protein from DNA which can recycle the mismatch repair proteins through 
another round of hydrolysis36,49,50.  The recycling of the mismatch repair complex in the 
ATPase assay as well the real-time binding-dissociation study on MSH2-MSH3 in the 
presence of ATP have reinforced this model and stabilized the notion that not only 
MSH2-MSH6 acts in this manner but also MSH2-MSH3. 
 The next step in understanding how MSH2-MSH3 functions will be to understand 
how the structural transformations upon lesion binding alter inherent ATP binding and 
signaling properties.  The use of the fluorescently labled MSH2-MSH3 proteins will 
allow us to visualize these changes in real time.  Protein footprinting by partial 
proteolysis has been used in the past to show that the MSH2-MSH3 complex undergoes 
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adenosine nucleotide-regulated conformational changes, but these experiments leave us 
in the dark with regards to the structure and nature of these changes, and how specifically 
they affect other functions of the protein13.  These experiments will be of great 
significance in trying to determine the role of MSH2-MSH3 in trinucleotide repeat 
expansion, as well as the mismatch repair pathway in general. 
 It is well known that bacterial MutS demonstrates ATPase activity that has been 
conserved in the yeast and human homologs51,52.  Most of the literature has focused on 
the MSH2-MSH6 heterodimer, and, as a result, much remains to be studied regarding the 
ATPase activity of MSH2-MSH3 and how it processes adenosine nucleotides upon lesion 
recognition.  Although recent literature has provided some insight, little work has been 
done to understand how each subunit interacts in processing ATP and ADP.  Here, the 
mutants that were created will allow examination of these issues.  Mutations in the 
Walker A box of both MSH2 and MSH3 will allow us to see how the protein uses 
adenylate to bind the DNA, and will also permit us to study how it processes dissociation 
from the DNA backbone after lesion binding.  The mutants will allow us to see which 
subunit of the dimer specifically is responsible in processing adenosine nucleotide during 
these processes. 
 This and future work will be important to the field of mismatch repair; to 
understand the mechanisms behind initiation, lesion recognition, and also downstream 
signaling of mismatch repair machinery.  How these events and defects in mismatch 
repair lead HNPCC and trinucleotide repeat expansion is still an area of active research 
and study.  Understanding and working out the underlying fundamental mechanisms and 
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models of these processes will open up new areas of research and expand the tools we 
have at our disposal to combat disease.    
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